Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term HIV Infections. Found 17 abstracts

Dash PK, Kaminski R, Bella R, Su H, Mathews S, Ahooyi TM, Chen C, Mancuso P, Sariyer R, Ferrante P, Donadoni M, Robinson JA, Sillman B, Lin Z, Hilaire JR, Banoub M, Elango M, Gautam N, Mosley RL, Poluektova LY, McMillan J, Bade AN, Gorantla S, Sariyer IK, Burdo TH, Young WB, Amini S, Gordon J, Jacobson JM, Edagwa B, Khalili K, Gendelman HE. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. Nat Commun. 2019 Jul 02;10(1):2753.   PMCID: PMC6606613
Santerre M, Chatila W, Wang Y, Mukerjee R, Sawaya BE. HIV-1 Nef promotes cell proliferation and microRNA dysregulation in lung cells. Cell cycle (Georgetown, Tex). 2019 Jan;18(2):130-42.
Zhou R, Wang X, Liu H, Guo L, Su Q, Wang H, Vasiliadis T, Ho W, Li J. GalNAc-Specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors. J Virol. 2018 Mar 15;92(6).   PMCID: PMC5827391
Kearns A, Gordon J, Burdo TH, Qin X. HIV-1-Associated Atherosclerosis: Unraveling the Missing Link. Journal of the American College of Cardiology. 2017 Jun 27;69(25):3084-98.   PMCID: PMC5512584
Kearns A, Gordon J, Burdo TH, Qin X. HIV-1-Associated Atherosclerosis: Unraveling the Missing Link. Journal of the American College of Cardiology. 2017 Jun 27;69(25):3084-98.   PMCID: PMC5512584
Sami Saribas A, Cicalese S, Ahooyi TM, Khalili K, Amini S, Sariyer IK. HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity. Cell death & disease. 2017 Jan 12;8(1):e2542.   PMCID: PMC5386374
Bass SB, Wolak C, Greener J, Tedaldi E, Nanavati A, Ruppert K, Gordon TF. Using perceptual mapping methods to understand gender differences in perceived barriers and benefits of clinical research participation in urban minority HIV+ patients. AIDS Care. 2016 Nov 17;28(4):528-36.
Bass SB, Wolak C, Greener J, Tedaldi E, Nanavati A, Ruppert K, Gordon TF. Using perceptual mapping methods to understand gender differences in perceived barriers and benefits of clinical research participation in urban minority HIV+ patients. AIDS Care. 2016 Jan;28(4):528-36.
Patel D, Antwi J, Koneru PC, Serrao E, Forli S, Kessl JJ, Feng L, Deng N, Levy RM, Fuchs JR, Olson AJ, Engelman AN, Bauman JD, Kvaratskhelia M, Arnold E. A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain. The Journal of biological chemistry. 2016 Nov 04;291(45):23569-77.   PMCID: PMC5095411
Barta SK. To be or not to be HIV+, that is no longer the question. Blood. 2015 Jul 09;126(2):124-6.
Flynn WF, Chang MW, Tan Z, Oliveira G, Yuan J, Okulicz JF, Torbett BE, Levy RM. Deep sequencing of protease inhibitor resistant HIV patient isolates reveals patterns of correlated mutations in Gag and protease. PLoS computational biology. 2015 Apr;11(4):e1004249.   PMCID: PMC4404092
Hou P, Chen S, Wang S, Yu X, Chen Y, Jiang M, Zhuang K, Ho W, Hou W, Huang J, Guo D. Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection. Sci Rep. 2015 Jan;5:15577.   PMCID: 4612538
Kogan M, Deshmane S, Sawaya BE, Gracely EJ, Khalili K, Rappaport J. Inhibition of NF-kappaB activity by HIV-1 Vpr is dependent on Vpr binding protein. Journal of cellular physiology. 2013 Apr;228(4):781-90.   PMCID: Pmc3604695
Weiner R, Ronsmans C, Dorman E, Jilo H, Muhoro A, Shulman C. Labour complications remain the most important risk factors for perinatal mortality in rural Kenya. Bulletin of the World Health Organization. 2003 Jan;81(8):561-6.
Cianfrocca M, Cooley TP, Lee JY, Rudek MA, Scadden DT, Ratner L, Pluda JM, Figg WD, Krown SE, Dezube BJ. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol. 2002 Jan;20(1):153-9.
Von Roenn JH, Cianfrocca M. Treatment of Kaposi's sarcoma. Cancer Treat Res. 2001 Jan;104:127-48.
Much JK, Cotteta TA. Stress of occupational exposure to blood or body fluids: managing the response. MEDSURG Nursing. 1993 Feb;2(1):49-56.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term HIV Infections

HIV Infections virology HIV-1 complications drug therapy genetics etiology Hiv-1 Female metabolism epidemiology drug effects administration & dosage Adult immunology Male pharmacology pathology Hiv Adolescent therapeutic use physiology Risk Factors Survival Rate clinical trials HIV Seropositivity Human Global Health Minority Groups antagonists & inhibitors Kaposi Sarcoma macrophage United States CRISPR-Cas Systems Attitudes Health Knowledge-Practice perceptual mapping Tg26 transgenic mice Signal Transduction Clinical Trials as Topic trends Communication Barriers Morbidity Atherosclerosis Perception Surveys and Questionnaires pathogenicity Trust psychology inflammation CD4-Positive T-Lymphocytes ethnology Cellular Immunity Young Adult Middle Aged blood Human Immunodeficiency Virus nef Gene Products therapy Autophagy Patient Acceptance of Health Care Focus Groups Anti-HIV Agents caspase-1 minorities Aged perceptions Cultured Cells Social Stigma Motivation inflammasome Urban Population Antineoplastic Agents immune activation Sex Factors aids Human Immunodeficiency Virus gag Gene Products fragment screening Molecular Models RNA Editing NF-kappa B Retinoids Clinical Trials Cell Line Argonaute Proteins Blood Carboxylic Acids Nonparametric Statistics mortality Catalytic Domain Non-Small-Cell Lung Carcinoma integrase Primary Cell Culture Interferon-beta X-Ray Crystallography microRNA biogenesis drug screening Mononuclear Leukocytes Cryotherapy lung cancer Cross-Sectional Studies Myeloid Cells Carrier Proteins Malaria Occupational Exposure Viral Load Tetracycline DEAD-box RNA Helicases Endothelial Growth Factors Treatment Outcome CXCR4 Receptors Viral DNA tm [Transmission] Jurkat Cells Oral Administration US Gov't Support-PHS Allosteric Regulation HEK293 Cells statistics & numerical data HIV Protease HIV Envelope Protein gp41 Cell Survival Practice Guidelines Combination Drug Therapy Highly Active Antiretroviral Therapy Prognosis Plant Lectins Extracellular Vesicles Recombinant Proteins Anthracyclines Human Immunodeficiency Virus vpr Gene Products human immunodeficiency virus (HIV) Liposomes Gene Editing Interferons Antineoplastic Combined Chemotherapy Protocols Drug Discovery Transfection Kenya Monoclonal Antibodies-Murine-Derived Ribonuclease III Physical Examination Respiratory Tract Neoplasms Disease Resistance Computational Biology CD4 Lymphocyte Count Matrix Metalloproteinases I-kappa B Proteins chemistry drug discovery Gelatinase A mitogenicity
Last updated on Monday, July 06, 2020